Geode Capital Management »

Enlivex Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $40k 10k 3.79
2023-09-30 $17k 10k 1.58
2023-06-30 $27k 10k 2.63
2023-03-31 $38k 10k 3.64
2022-12-31 $40k 10k 3.84
2022-09-30 $44k 10k 4.22
2022-06-30 $47k 10k 4.51
2022-03-31 $58k 10k 5.57
2021-12-31 $65k 10k 6.24
2021-09-30 $102k 10k 9.79